China Universal Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $700 Million
- Q2 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 10,666 shares of RCKT stock, worth $180,895. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,666
Previous 17,365
38.58%
Holding current value
$180,895
Previous $467,000
50.96%
% of portfolio
0.03%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$300 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$155 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$98.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$73.4 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.28B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...